Glaukos Total Liabilities 2014-2025 | GKOS

Glaukos total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Glaukos total liabilities for the quarter ending March 31, 2025 were $0.202B, a 58.1% decline year-over-year.
  • Glaukos total liabilities for 2024 were $0.208B, a 56.58% decline from 2023.
  • Glaukos total liabilities for 2023 were $0.479B, a 1.33% increase from 2022.
  • Glaukos total liabilities for 2022 were $0.472B, a 2.13% increase from 2021.
Glaukos Annual Total Liabilities
(Millions of US $)
2024 $208
2023 $479
2022 $472
2021 $463
2020 $338
2019 $145
2018 $33
2017 $28
2016 $17
2015 $21
2014 $30
2013 $24
Glaukos Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $202
2024-12-31 $208
2024-09-30 $258
2024-06-30 $255
2024-03-31 $483
2023-12-31 $479
2023-09-30 $471
2023-06-30 $468
2023-03-31 $464
2022-12-31 $472
2022-09-30 $460
2022-06-30 $469
2022-03-31 $455
2021-12-31 $463
2021-09-30 $463
2021-06-30 $459
2021-03-31 $433
2020-12-31 $338
2020-09-30 $333
2020-06-30 $333
2020-03-31 $138
2019-12-31 $145
2019-09-30 $117
2019-06-30 $114
2019-03-31 $43
2018-12-31 $33
2018-09-30 $27
2018-06-30 $23
2018-03-31 $20
2017-12-31 $28
2017-09-30 $21
2017-06-30 $20
2017-03-31 $15
2016-12-31 $17
2016-09-30 $19
2016-06-30 $19
2016-03-31 $18
2015-12-31 $21
2015-09-30 $23
2015-06-30 $33
2015-03-31 $33
2014-12-31 $30
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $24
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.932B $0.383B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $183.532B 80.39
Thermo Fisher Scientific (TMO) United States $164.157B 19.86
Edwards Lifesciences (EW) United States $45.784B 30.02
Alcon (ALC) Switzerland $43.149B 29.16
IDEXX Laboratories (IDXX) United States $42.895B 49.29
DexCom (DXCM) United States $32.690B 50.53
IQVIA Holdings (IQV) United States $28.164B 15.77
Mettler-Toledo (MTD) United States $25.437B 30.25
STERIS (STE) Ireland $22.432B 24.70
Waters (WAT) United States $21.001B 29.63
SONOVA HOLDING (SONVY) Switzerland $17.363B 0.00
Hologic (HOLX) United States $14.645B 15.91
Sysmex ADR (SSMXY) Japan $10.626B 30.14
Penumbra (PEN) United States $9.214B 72.32
Masimo (MASI) United States $8.837B 32.60
Globus Medical (GMED) United States $7.733B 18.43
Teleflex (TFX) United States $5.144B 8.49
Integer Holdings (ITGR) United States $4.186B 21.93
TransMedics (TMDX) United States $3.804B 82.69
PROCEPT BioRobotics (PRCT) United States $3.134B 0.00
LivaNova (LIVN) United Kingdom $2.417B 14.39
Veracyte (VCYT) United States $2.121B 29.76
Nihon Kohden (NHNKY) Japan $1.942B 22.27
Elekta AB (EKTAY) Sweden $1.903B 17.10
Alphatec Holdings (ATEC) United States $1.606B 0.00
Artivion (AORT) United States $1.343B 125.84
Pulse Biosciences (PLSE) United States $1.078B 0.00
OPKO Health (OPK) United States $1.071B 0.00
Tandem Diabetes Care (TNDM) United States $1.038B 0.00
Integra LifeSciences Holdings (IART) United States $0.978B 5.20
SiBone (SIBN) United States $0.733B 0.00
IRadimed (IRMD) United States $0.732B 37.14
Semler Scientific (SMLR) United States $0.623B 13.51
AVANOS MEDICAL, INC (AVNS) United States $0.552B 8.58
Beta Bionics (BBNX) United States $0.549B 0.00
AxoGen (AXGN) United States $0.542B 0.00
OrthoPediatrics (KIDS) United States $0.532B 0.00
Mesa Laboratories (MLAB) United States $0.471B 11.05
Pacific Biosciences Of California (PACB) United States $0.441B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.433B 0.00
Delcath Systems (DCTH) United States $0.395B 0.00
AngioDynamics (ANGO) United States $0.378B 0.00
Treace Medical Concepts (TMCI) United States $0.377B 0.00
RxSight (RXST) United States $0.325B 0.00
ClearPoint Neuro (CLPT) United States $0.319B 0.00
NeuroPace (NPCE) United States $0.312B 0.00
Alpha Tau Medical (DRTS) Israel $0.260B 0.00
908 Devices (MASS) United States $0.249B 0.00
Neuronetics (STIM) United States $0.236B 0.00
Tactile Systems Technology (TCMD) United States $0.232B 14.03
Inogen (INGN) United States $0.186B 0.00
Spectral Diagnostics (EDTXF) Canada $0.178B 0.00
CVRx (CVRX) United States $0.178B 0.00
Sight Sciences (SGHT) United States $0.176B 0.00
LENSAR (LNSR) United States $0.154B 0.00
Rapid Micro Biosystems (RPID) United States $0.147B 0.00
Biosig Technologies (BSGM) United States $0.143B 0.00
Accuray (ARAY) United States $0.140B 0.00
Lucid Diagnostics (LUCD) United States $0.123B 0.00
Atossa Genetics (ATOS) United States $0.121B 0.00
Monogram Orthopaedics (MGRM) United States $0.117B 0.00
Anteris Technologies Global (AVR) Australia $0.115B 0.00
Microbot Medical (MBOT) United States $0.095B 0.00
EnVVeno Medical (NVNO) United States $0.073B 0.00
Spectral AI (MDAI) United States $0.072B 0.00
InspireMD (NSPR) United States $0.072B 0.00
Sensus Healthcare (SRTS) United States $0.068B 41.60
Hyperfine (HYPR) United States $0.060B 0.00
EDAP TMS S.A (EDAP) France $0.057B 0.00
QT Imaging Holdings (QTIH) United States $0.056B 0.00
Covalon Technologies (CVALF) Canada $0.054B 21.96
Vicarious Surgical (RBOT) United States $0.048B 0.00
Precision Optics (POCI) United States $0.038B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Adagio Medical Holdings (ADGM) United States $0.026B 0.00
Baird Medical Investment Holdings (BDMD) $0.022B 0.00
NexGel (NXGL) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
WORK Medical Technology Group (WOK) China $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.45